These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 23153217

  • 1. Percutaneous CT-guided radiofrequency ablation for unresectable hepatocellular carcinoma pulmonary metastases.
    Li X, Wang J, Li W, Huang Z, Fan W, Chen Y, Shen L, Pan T, Wu P, Zhao M.
    Int J Hyperthermia; 2012; 28(8):721-8. PubMed ID: 23153217
    [Abstract] [Full Text] [Related]

  • 2. Comparative survival analysis in patients with pulmonary metastases from nasopharyngeal carcinoma treated with radiofrequency ablation.
    Pan CC, Wu PH, Yu JR, Li W, Huang ZL, Wang JP, Zhao M.
    Eur J Radiol; 2012 Apr; 81(4):e473-7. PubMed ID: 21700408
    [Abstract] [Full Text] [Related]

  • 3. Treatment of pulmonary colorectal metastases by radiofrequency ablation.
    Petre EN, Jia X, Thornton RH, Sofocleous CT, Alago W, Kemeny NE, Solomon SB.
    Clin Colorectal Cancer; 2013 Mar; 12(1):37-44. PubMed ID: 23026111
    [Abstract] [Full Text] [Related]

  • 4. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
    Wu J, Chen MH, Yang W, Wu W, Yan K.
    Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
    [Abstract] [Full Text] [Related]

  • 5. [Effect and prognostic analysis of radiofrequency ablation in treating advanced hepatocellular carcinoma].
    Wu J, Chen MH, Yan K, Wu W, Yang W.
    Zhonghua Yi Xue Za Zhi; 2012 Mar 20; 92(11):735-8. PubMed ID: 22781351
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. CT-guided radiofrequency ablation after with transarterial chemoembolization in treating unresectable hepatocellular carcinoma with long overall survival improvement.
    Zhao M, Wang JP, Pan CC, Li W, Huang ZL, Zhang L, Fang WJ, Jiang Y, Li XS, Wu PH.
    Eur J Radiol; 2012 Oct 20; 81(10):2717-25. PubMed ID: 22245655
    [Abstract] [Full Text] [Related]

  • 8. Percutaneous radiofrequency ablation for unresectable pulmonary metastases from renal cell carcinoma.
    Soga N, Yamakado K, Gohara H, Takaki H, Hiraki T, Yamada T, Arima K, Takeda K, Kanazawa S, Sugimura Y.
    BJU Int; 2009 Sep 20; 104(6):790-4. PubMed ID: 19338555
    [Abstract] [Full Text] [Related]

  • 9. Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients.
    Simon CJ, Dupuy DE, DiPetrillo TA, Safran HP, Grieco CA, Ng T, Mayo-Smith WW.
    Radiology; 2007 Apr 20; 243(1):268-75. PubMed ID: 17392258
    [Abstract] [Full Text] [Related]

  • 10. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
    Zytoon AA, Ishii H, Murakami K, El-Kholy MR, Furuse J, El-Dorry A, El-Malah A.
    Jpn J Clin Oncol; 2007 Sep 20; 37(9):658-72. PubMed ID: 17766723
    [Abstract] [Full Text] [Related]

  • 11. Intraoperative radiofrequency ablation (RFA) for irresectable liver malignancies.
    Tepel J, Hinz S, Klomp HJ, Kapischke M, Kremer B.
    Eur J Surg Oncol; 2004 Jun 20; 30(5):551-5. PubMed ID: 15135485
    [Abstract] [Full Text] [Related]

  • 12. [Prognosis and risk factors for recurrence of small liver cancer after a single session of percutaneous radiofrequency ablation].
    Xia JL, Ye SL, Zou JH, Ren ZG, Gan YH, Wang YH, Chen Y, Ge NL, Tang ZY, Yang BH.
    Ai Zheng; 2004 Sep 20; 23(9):977-80. PubMed ID: 15363186
    [Abstract] [Full Text] [Related]

  • 13. Percutaneous radiofrequency ablation for pulmonary metastases from hepatocellular carcinoma: results of a multicenter study in Japan.
    Hiraki T, Yamakado K, Ikeda O, Matsuoka T, Kaminou T, Yamagami T, Gobara H, Mimura H, Kawanaka K, Takeda K, Yamashita Y, Inoue Y, Ogawa T, Nishimura T, Kanazawa S.
    J Vasc Interv Radiol; 2011 Jun 20; 22(6):741-8. PubMed ID: 21531575
    [Abstract] [Full Text] [Related]

  • 14. Simultaneous computed tomography-guided biopsy and radiofrequency ablation of solitary pulmonary malignancy in high-risk patients.
    Schneider T, Puderbach M, Kunz J, Bischof A, Giesel FL, Dienemann H, Herth FJ, Schnabel PA, Safi S, Hoffmann H, Heussel CP.
    Respiration; 2012 Jun 20; 84(6):501-8. PubMed ID: 23037897
    [Abstract] [Full Text] [Related]

  • 15. Effectiveness and safety in radiofrequency ablation of pulmonary metastases from HCC: a five years study.
    Lassandro G, Picchi SG, Bianco A, Di Costanzo G, Coppola A, Ierardi AM, Lassandro F.
    Med Oncol; 2020 Mar 12; 37(4):25. PubMed ID: 32166529
    [Abstract] [Full Text] [Related]

  • 16. [Comparison of safety and efficacy for transcatheter arterial chemoembolization alone and plus radiofrequency ablation in the treatment of single branch portal vein tumor thrombus of hepatocellular carcinoma and their prognosis factors].
    Zhao M, Wang JP, Li W, Huang ZL, Zhang FJ, Fan WJ, Zhang L, Li XS, Pan CC, Wu PH.
    Zhonghua Yi Xue Za Zhi; 2011 May 10; 91(17):1167-72. PubMed ID: 21756768
    [Abstract] [Full Text] [Related]

  • 17. Frequency and risk factors of various complications after computed tomography-guided radiofrequency ablation of lung tumors.
    Okuma T, Matsuoka T, Yamamoto A, Oyama Y, Toyoshima M, Nakamura K, Inoue Y.
    Cardiovasc Intervent Radiol; 2008 May 10; 31(1):122-30. PubMed ID: 17985181
    [Abstract] [Full Text] [Related]

  • 18. Is percutaneous radiofrequency thermal ablation of hepatocellular carcinoma a safe procedure?
    Zavaglia C, Corso R, Rampoldi A, Vinci M, Belli LS, Vangeli M, Solcia M, Castoldi C, Prisco C, Vanzulli A, Pinzello G.
    Eur J Gastroenterol Hepatol; 2008 Mar 10; 20(3):196-201. PubMed ID: 18301300
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.